Biocompatible surgical compositions
View Patent ↗Biocompatible synthetic macromer compositions are provided including a first polymer having multiple functional groups and a second functionalized polyurethane prepolymer, which can be employed as an adhesive or sealant for medical/surgical uses.
1. A biocompatible synthetic macromer composition comprising:
a first polymer having the structure
R″—[R 1 —X] n (VII)
wherein R″ is selected from the group consisting of polysaccharides and polyols, R 1 is a poly(hydroxy) acid, X is a functional group selected from the group consisting of epoxy, halogen, isocyanate, chlorophosphates, anhydrides, and combinations thereof, and n is a number from 1 to 10; and
a second polymer comprising a functionalized polyurethane prepolymer having the structure
(R 4 ) m —((Y) p -D-(Y) p ) z —(R 5 ) m (IX)
wherein Y is a polymer backbone, D is selected from the group consisting of cyclodextrin, sorbitol, polyphenol and polyglycerol, R 4 and R 5 can be the same or different and are selected from the group consisting of NCO, CHO, and COOH, m is a number from about 1 to about 50, p is a number from about 1 to about 30, and z is a number from about 2 to about 20.
2. A biocompatible synthetic macromer composition as in claim 1 , wherein the X groups present on the first polymer are the same.
3. A biocompatible synthetic macromer composition as in claim 1 , wherein the X groups present on the first polymer are different.
4. A biocompatible synthetic macromer composition as in claim 1 , wherein R″ comprises a polyethylene glycol.
5. A biocompatible synthetic macromer composition as in claim 1 , wherein R″ comprises a methoxy polyethylene glycol.
6. A biocompatible synthetic macromer composition as in claim 1 , wherein R 4 and R 5 are the same.
7. A biocompatible synthetic macromer composition as in claim 1 , wherein R 4 and R 5 are different.
8. A biocompatible synthetic macromer composition as in claim 1 , wherein Y comprises a polyalkylene oxide.
9. A biocompatible synthetic macromer composition as in claim 8 , wherein Y comprises a polyethylene glycol.
10. A biocompatible synthetic macromer composition as in claim 1 , further comprising an amine cross-linker.
11. A biocompatible synthetic macromer composition as in claim 10 , wherein said amine cross-linker is selected from the group consisting of diamines, aromatic amines, polyamines, and polyamidoamines.
12. A biocompatible synthetic macromer composition as in claim 1 , wherein the biocompatible synthetic macromer composition further includes a component selected from the group consisting of biologically active agents and medicinal agents.
13. A biocompatible synthetic macromer composition as in claim 1 , further comprising an enzyme, wherein the enzyme increases the degradation rate of the biocompatible synthetic macromer composition.
14. A method for closing a wound comprising:
applying the biocompatible synthetic macromer composition of claim 1 to said wound; and
allowing the biocompatible synthetic macromer composition to set thereby closing said wound.
15. The method of claim 14 wherein the wound is a surgical incision.
16. A method for filling a void in animal tissue comprising:
applying the biocompatible synthetic macromer composition of claim 1 to said void; and
allowing the biocompatible synthetic macromer composition to set thereby filling said void.
17. A method for adhering a medical device to a surface of animal tissue comprising the steps of:
applying the biocompatible synthetic macromer composition of claim 1 to said device, said surface or both;
bringing the device, biocompatible synthetic macromer composition and surface into contact with each other; and
allowing the biocompatible synthetic macromer composition to set thereby adhering the device and surface to each other.
18. The method of claim 17 wherein said medical device is an implant.